We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RYAM icon
3651
Rayonier Advanced Materials
RYAM
$590M
$26K ﹤0.01%
3,955
-7,917
-67% -$64.5K
SFST icon
3652
Southern First Bancshares
SFST
$603M
$26K ﹤0.01%
514
-141
-22% -$7.29K
SMMT icon
3653
Summit Therapeutics
SMMT
$12.1B
$26K ﹤0.01%
3,436
-1,381
-29% -$9.06K
TPVG icon
3654
TriplePoint Venture Growth BDC
TPVG
$214M
$26K ﹤0.01%
1,663
+1,440
+646% +$22.2K
VTLE
3655
DELISTED
Vital Energy
VTLE
$26K ﹤0.01%
278
+229
+467% +$11.8K
XCUR icon
3656
Exicure
XCUR
$8.92M
$26K ﹤0.01%
115
+79
+219% +$20.7K
XXII
3657
22nd Century Group
XXII
$1.52M
0
EGIO
3658
DELISTED
Edgio, Inc. Common Stock
EGIO
$26K ﹤0.01%
211
+48
+29% +$6.34K
CSTR
3659
DELISTED
CapStar Financial Holdings, Inc
CSTR
$26K ﹤0.01%
1,285
+111
+9% +$2.23K
KVSA
3660
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
$26K ﹤0.01%
2,657
+2,308
+661% +$23.5K
MSDAU
3661
DELISTED
MSD Acquisition Corp. Unit
MSDAU
$26K ﹤0.01%
2,587
+2,187
+547% +$22.3K
AGTC
3662
DELISTED
Applied Genetic Technologies Corporation
AGTC
$26K ﹤0.01%
6,527
-13,916
-68% -$57.7K
PAE
3663
DELISTED
PAE Incorporated Class A Common Stock
PAE
$26K ﹤0.01%
2,867
-3,217
-53% -$27.7K
WTRE
3664
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
$26K ﹤0.01%
730
-563
-44% -$19.6K
AIRT icon
3665
Air T
AIRT
$84.8M
$25K ﹤0.01%
1,036
-1,153
-53% -$26.4K
ARKW icon
3666
ARK Web x.0 ETF
ARKW
$1.77B
$25K ﹤0.01%
160
-15,169
-99% -$2.18M
ATEN icon
3667
A10 Networks
ATEN
$1.97B
$25K ﹤0.01%
2,259
-2,183
-49% -$21.1K
AXGN icon
3668
Axogen
AXGN
$2.61B
$25K ﹤0.01%
1,150
-1,014
-47% -$20.5K
BOLT icon
3669
Bolt Biotherapeutics
BOLT
$7.65M
$25K ﹤0.01%
81
+28
+53% +$11.4K
CCRN
3670
DELISTED
Cross Country Healthcare
CCRN
$25K ﹤0.01%
1,505
-1,484
-50% -$22.7K
CLBK icon
3671
Columbia Financial
CLBK
$1.15B
$25K ﹤0.01%
1,450
-4,818
-77% -$84.9K
CRK icon
3672
Comstock Resources
CRK
$4.23B
$25K ﹤0.01%
3,736
-1,482
-28% -$8.54K
CYD icon
3673
China Yuchai International
CYD
$1.75B
$25K ﹤0.01%
1,576
+1,017
+182% +$16.5K
EVC icon
3674
Entravision Communication
EVC
$852M
$25K ﹤0.01%
3,783
-1,813
-32% -$8.19K
GLOB icon
3675
Globant
GLOB
$1.68B
$25K ﹤0.01%
113
-2,581
-96% -$567K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.